- Home
- CALC vs MTEN Comparison
CALC vs MTEN Comparison
Compare CALC & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- MTEN
- Stock Information
- Founded
- CALC 2011
- MTEN 2015
- Country
- CALC United States
- MTEN China
- Employees
- CALC N/A
- MTEN N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- MTEN Building Products
- Sector
- CALC Health Care
- MTEN Industrials
- Exchange
- CALC Nasdaq
- MTEN Nasdaq
- Market Cap
- CALC 22.9M
- MTEN 83.1M
- IPO Year
- CALC N/A
- MTEN 2024
- Fundamental
- Price
- CALC $1.60
- MTEN $10.72
- Analyst Decision
- CALC Strong Buy
- MTEN
- Analyst Count
- CALC 3
- MTEN 0
- Target Price
- CALC $16.33
- MTEN N/A
- AVG Volume (30 Days)
- CALC 28.4K
- MTEN 60.1K
- Earning Date
- CALC 08-11-2025
- MTEN 04-30-2025
- Dividend Yield
- CALC N/A
- MTEN N/A
- EPS Growth
- CALC N/A
- MTEN N/A
- EPS
- CALC N/A
- MTEN N/A
- Revenue
- CALC N/A
- MTEN $10,120,257.00
- Revenue This Year
- CALC N/A
- MTEN N/A
- Revenue Next Year
- CALC N/A
- MTEN N/A
- P/E Ratio
- CALC N/A
- MTEN N/A
- Revenue Growth
- CALC N/A
- MTEN 23.03
- 52 Week Low
- CALC $1.42
- MTEN $1.81
- 52 Week High
- CALC $5.97
- MTEN $16.60
- Technical
- Relative Strength Index (RSI)
- CALC 32.78
- MTEN N/A
- Support Level
- CALC $1.48
- MTEN N/A
- Resistance Level
- CALC $1.79
- MTEN N/A
- Average True Range (ATR)
- CALC 0.12
- MTEN 0.00
- MACD
- CALC -0.02
- MTEN 0.00
- Stochastic Oscillator
- CALC 0.00
- MTEN 0.00
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.